Skip to main content
Year archive

TYK Medicines, Inc — 2026 filings

All 23 regulatory filings released by TYK Medicines, Inc (2410) in 2026, sourced directly from the official regulator.

23 Filings
2026 Period
2026 filings (23)
Filing Released Lang
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING OF 2025 TO BE HELD ON TUESDAY, JUNE 23, 2026 AND ANY ADJOURNMENT THEREOF
Proxy Solicitation & Information Statement
2026-05-22 English
NOTICE OF THE 2025 ANNUAL GENERAL MEETING
AGM Information
2026-05-22 English
CIRCULAR OF 2025 AGM
Proxy Solicitation & Information Statement
2026-05-22 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2026
Regulatory Filings
2026-05-06 English
Annual Report 2025
Regulatory Filings
2026-04-29 English
(revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2026
Share Issue/Capital Change
2026-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2026
Regulatory Filings
2026-04-02 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025; AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Annual Report FY 2025
2026-03-30 English
VOLUNTARY ANNOUNCEMENT - RESEARCH RESULTS FOR FIVE INNOVATIVE DRUG PROJECTS WILL BE PRESENTED AT 2026 AACR ANNUAL MEETING
Regulatory Filings
2026-03-25 English
Next Day Disclosure Returns
Share Issue/Capital Change
2026-03-04 English
INSIDE INFORMATION - COMPLETION OF THE H SHARE FULL CIRCULATION
Share Issue/Capital Change
2026-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2026
Regulatory Filings
2026-03-04 English
CONNECTED TRANSACTION - DEEMED DISPOSAL OF A SUBSIDIARY
M&A Activity
2026-02-27 English
INSIDE INFORMATION - GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE FOR IMPLEMENTATION OF THE H SHARE FULL CIRCULATION
Share Issue/Capital Change
2026-02-12 English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR ASANDEUTERTINIB (TY-9591) BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2026-02-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2026
Share Issue/Capital Change
2026-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Regulatory Filings
2026-02-02 English
VOLUNTARY ANNOUNCEMENT - INCLUSION OF ASANDEUTERTINIB (TY-9591) IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE CENTER FOR DRUG EVALUATION OF THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2026-01-29 English
INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION APPLICATION OF THE COMPANY
Regulatory Filings
2026-01-23 English
VOLUNTARY ANNOUNCEMENT - THE COMPANY HAS BEEN GRANTED THE DRUG MANUFACTURING LICENSE BY THE DRUG ADMINISTRATION OF ZHEJIANG PROVINCE
Regulatory Filings
2026-01-23 English
VOLUNTARY ANNOUNCEMENT - PROPOSED INCLUSION OF ASANDEUTERTINIB (TY-9591) IN PRIORITY REVIEW&#x3b; AND UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
Regulatory Filings
2026-01-07 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2025
Share Issue/Capital Change
2026-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change
2026-01-02 English